Novozymes Income from Continuous Operations 2011-2024 | NVZMY
Novozymes annual/quarterly income from continuous operations history and growth rate from 2011 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Novozymes income from continuous operations for the quarter ending June 30, 2024 was $0M, a 100% decline year-over-year.
- Novozymes income from continuous operations for the twelve months ending June 30, 2024 was $0.326B, a 36.22% decline year-over-year.
- Novozymes annual income from continuous operations for 2024 was $0.331B, a 25.01% decline from 2023.
- Novozymes annual income from continuous operations for 2023 was $0.441B, a 15.46% decline from 2022.
- Novozymes annual income from continuous operations for 2022 was $0.522B, a 4.31% increase from 2021.
Novozymes Annual Income from Continuous Operations
(Millions of US $) |
| 2024 |
$331 |
| 2023 |
$441 |
| 2022 |
$522 |
| 2021 |
$500 |
| 2020 |
$433 |
| 2019 |
$473 |
| 2018 |
$511 |
| 2017 |
$474 |
| 2016 |
$453 |
| 2015 |
$420 |
| 2014 |
$394 |
| 2013 |
$400 |
| 2012 |
$351 |
| 2011 |
$325 |
| 2010 |
$287 |
Novozymes Quarterly Income from Continuous Operations
(Millions of US $) |
| 2024-06-30 |
|
| 2023-12-31 |
$100 |
| 2023-09-30 |
$136 |
| 2023-06-30 |
$90 |
| 2023-03-31 |
$115 |
| 2022-12-31 |
$123 |
| 2022-09-30 |
$156 |
| 2022-06-30 |
$117 |
| 2022-03-31 |
$127 |
| 2021-12-31 |
$95 |
| 2021-09-30 |
$134 |
| 2021-06-30 |
$129 |
| 2021-03-31 |
$143 |
| 2020-12-31 |
$106 |
| 2020-09-30 |
$112 |
| 2020-06-30 |
$95 |
| 2020-03-31 |
$120 |
| 2019-12-31 |
$137 |
| 2019-09-30 |
$95 |
| 2019-06-30 |
$135 |
| 2019-03-31 |
$106 |
| 2018-12-31 |
$128 |
| 2018-09-30 |
$126 |
| 2018-06-30 |
$124 |
| 2018-03-31 |
$133 |
| 2017-12-31 |
$125 |
| 2017-09-30 |
$129 |
| 2017-06-30 |
$109 |
| 2017-03-31 |
$111 |
| 2016-12-31 |
$117 |
| 2016-09-30 |
$112 |
| 2016-06-30 |
$114 |
| 2016-03-31 |
$110 |
| 2015-12-31 |
$102 |
| 2015-09-30 |
$111 |
| 2015-06-30 |
$101 |
| 2015-03-31 |
$102 |
| 2014-12-31 |
$94 |
| 2014-09-30 |
$108 |
| 2014-06-30 |
$106 |
| 2014-03-31 |
$128 |
| 2013-12-31 |
$102 |
| 2013-09-30 |
$105 |
| 2013-06-30 |
$100 |
| 2013-03-31 |
$90 |
| 2012-12-31 |
$86 |
| 2012-09-30 |
$88 |
| 2012-06-30 |
$81 |
| 2012-03-31 |
$90 |
| 2011-12-31 |
$65 |
| 2011-09-30 |
$98 |
| 2011-06-30 |
$88 |
| 2011-03-31 |
$90 |
| 2010-12-31 |
$64 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$26.253B |
$2.598B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
